Skip to main content
. 2017 Oct 6;7(10):e015112. doi: 10.1136/bmjopen-2016-015112

Table 3.

No of total death, CVD death, non-CVD death and its subtypes according to hs-CRP levels

Cause of death Total hs-CRP levels (mg/L) χ2test p value
<3.0 3.1–5.4 5.5–11.5 11.6–33.2 ≥33.3
No of total deaths 1156 517 116 134 149 240
No of CVD deaths, n (%) 976 (84.4) 484 (93.6) 106 (91.4) 116 (86.6) 120 (80.5) 150 (62.5)
No of non-CVD deaths, n (%) 180 (15.6) 33 (6.8) 10 (8.6) 18 (13.4) 29 (19.5) 90 (37.5) 127.9 <0.001
 No of infection deaths, n (%) 64 (5.5) 6 (1.2) 3 (2.6) 5 (3.7) 9 (6.0) 41 (17.1) 101.7 <0.001
 No of neoplasm deaths, n (%) 49 (4.2) 6 (1.2) 2 (1.7) 5 (3.7) 7 (4.7) 29 (12.1) 67.4 <0.001
 No of other deaths, n (%) 67 (5.8) 21 (4.1) 5 (4.3) 8 (5.9) 13 (8.7) 20 (8.3) 15.7 0.003

Infection deaths: deaths from septicaemia, bacteraemia, endocarditis, pulmonary infections (eg, viral pneumonia, bacterial pneumonia, influenza with respiratory manifestations and abscess of lung or mediastinum), genitourinary infections (eg, urinary tract infection, pyelonephritis and perinephric abscess), gastrointestinal infections (eg, diverticulitis, C. difficile colitis and perirectal abscess), peritonitis, soft-tissue infections (eg, cellulitis, necrotising fasciitis and gangrene) and joint or bone infections (eg, infective arthritis and osteomyelitis). Neoplasm deaths: deaths from International Statistical Classification of Diseases and related problems 10th revision C00–D48. Other deaths: deaths from other than the causes listed above.

CVD, cardiovascular disease; hs-CRP, high-sensitivity C reactive protein.